Innate immunity serves as the first line of the body defense against invading pathogenic microorganisms, and the innate immune system of mammals detects pathogenic microorganisms invading the body through pattern recognition receptors encoded by germline genes, of which Toll-like receptors (TLRs) play an important role in initiating innate immune responses by recognizing pathogen-associated molecular patterns (the conserved molecular structures of pathogens) and damage-associated molecular patterns (components released by damaged own cells and tissues) [1–3]. Activation of TLRs can mediate inflammatory response, modulation of cell cycle, apoptosis and other biological effects [4]. TLRs, as a “bridge” connecting innate immunity and adaptive immunity, according to sub-cellular localization, are classified into two types. One type is located at the plasma membrane, such as TLR1, 2, 4, 5, 6 and TLR10, and mainly recognizes bacterial cell wall components and related molecules. The other type is expressed on the endosomes and phagosome membranes, including TLR3, 7, 8 and TLR9, which mainly recognizes bacterial and viral nuclear components [5, 6].
TLR8, as one of the main members of the TLR7/8/9 subfamily, is a type I membrane-spanning proteins and consists of an extracellular leucine-rich repeat (LRR) domain which is responsible for ligand recognition, a transmembrane domain and an intracellular Toll/IL-1 receptor (TIR) domain responsible for signal transduction [7, 8]. TLR8 is mainly expressed in monocytes/ macrophages, neutrophils, dendritic cells, natural killer cells [9, 10], and can recognize single-stranded RNA [9, 11], synthetic oligonucleotides [10], guanosine analogs with antiviral activities [11], synthetic imidazoquinoline compounds [12], and activate specific signaling pathways to exert multiple immunological functions. TLR8 recognizes the corresponding pathogen-associated molecular patterns (PAMPs), and brings the intracellular TIR domains closer to each other by binding with PAMPs, thereby initiating signal transduction. The TIR domains can bind to the adapter protein myeloid differentiation factor 88 (MyD88) through homotypic interaction, which can recruit IL-1R-associated kinase 1 (IRAK1) and 4, and activate ubiquitin ligase TNF receptor-associated factor 6 (TRAF6). TRAF6 can activate the downstream transcription factors NF-κB and interferon regulatory factor 7 (IRF7) by initiating the corresponding signal transduction pathways. Ultimately, pro-inflammatory cytokines, such as TNF-α, IL-1β, IL-6, IL-12, IL-27, and type I interferon are produced to participate in the body's innate and adaptive immune response [7, 13, 14]. Activation of TLR8 signaling pathway can produce IFN-α and pro-inflammatory cytokines such as TNF-α, IL-1β, IL-6, IL-12, etc., suggesting that TLR8 plays an important role in cellular immunity, anti-tumor, antiviral and anti-infection of the body. In addition, Th2-type cytokines, such as IL-4, IL-5 and IL-13, are associated with the occurrence and development of some allergic diseases. TLR8 can exert anti-allergic effects by inhibiting the abnormal secretion of Th2-type cytokines [15]. Crucially, CD4+ regulatory T (Treg) cells can suppress immune responses of body, while TLR8 can activate the TLR8-MyD88-IRAK4 signaling pathway through recognition of ligands to inhibit the immunosuppressive function of Treg cells, thereby enhancing the body's anti-tumour immunity [16]. Therefore, basic studies on the distribution, expression and signaling mechanism of TLR8 are of great significance for revealing the relevant mechanisms of the body's anti-infection, anti-tumor and anti-allergy.
As of now, studies on TLR8 have been reported in human [17, 18] and many animals, mainly including bovine [19], goat [20], porcine [21], equine [22], nyctereutes procyonoides [23], mouse [24, 25] and other animals [26–28]. These studies are mainly concerned with the molecular cloning, characterization and expression patterns of TLR8 [22–28], the development and clinical application of TLR8 agonists [17, 29], especially in application of tumor immunotherapy [17], the mechanism of TLR8 signaling pathway and anti-infection [19, 21, 26], and the relationship between TLR8 and the occurrence and development of some clinical diseases has also been reported, such as tumors [17], tuberculosis [18] and asthma [29]. Bactrian camel, as an important special economic animal in China, is a particularly special species because of its ability to survive in arid and semi-arid desert environments [30]. Compared with other ruminants, Bactrian camels have unique biological characteristics, such as greater resistance to rough-feeding, hunger, thirst, heat, cold and so on [31, 32]. Meanwhile, studies on the mucosal immunity of Bactrian camels have also revealed that they have unique mucosal immunological characteristics [33, 34]. The spleen, as the largest immune organ of Bactrian camels, is a key site for the migration and settlement of lymphocytes and immune response, and has biological functions such as filtering and storing blood, regulating blood volume and participating in the body's immune response [35]. As a highly expressed site of TLR8, the spleen can generate corresponding immune responses when the body is stimulated by antigens. The multiple biological effects mediated by TLR8 may be an essential part of maintaining the strong immune function of Bactrian camels. Although the distribution and expression patterns of TLR8 have been elucidated in many animals, studies on Bactrian camel TLR8 have not been reported, and the distribution characteristics and age-related changes of TLR8 in the spleen of Bactrian camel remains unclear. As an important reagent necessary for basic research, polyclonal antibody is widely used due to its short preparation cycle and high cost-effectiveness. However, there are still no commercial Bactrian camel TLR8 antibodies. To clarify these questions, in this study, the TLR8 recombinant protein of Bactrian camel was successfully obtained through the prokaryotic expression, and rabbit anti-Bactrian camel TLR8 polyclonal antibody was prepared. The distribution characteristics and age-related changes of TLR8 in the spleen of Bactrian camel were carefully observed, analyzed and compared. These data will provide support for further studies on the immunomorphology and immunosenescence of Bactrian camel spleen and mechanism of TLR8 signaling pathway.